{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:44:00Z","timestamp":1790315040189,"version":"4.1.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1001\/jamacardio.2018.4729","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T15:07:53Z","timestamp":1557328073000},"page":"526","source":"Crossref","is-referenced-by-count":37,"title":["Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation"],"prefix":"10.1001","volume":"4","author":[{"given":"Ramon","family":"Corbalan","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Diseases, Catholic University School of Medicine, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bassand","sequence":"additional","affiliation":[{"name":"University of Besan\u00e7on, Besan\u00e7on, France"},{"name":"Thrombosis Research Institute, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Illingworth","sequence":"additional","affiliation":[{"name":"Thrombosis Research Institute, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ambrosio","sequence":"additional","affiliation":[{"name":"University of Perugia School of Medicine, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Camm","sequence":"additional","affiliation":[{"name":"St George\u2019s University of London, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fitzmaurice","sequence":"additional","affiliation":[{"name":"Warwick Medical School, University of Warwick, Coventry, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A. A.","family":"Fox","sequence":"additional","affiliation":[{"name":"Edinburgh University, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Goto","sequence":"additional","affiliation":[{"name":"Tokai University School of Medicine, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Haas","sequence":"additional","affiliation":[{"name":"Formerly at Klinikum rechts der Isar, Technical University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Kayani","sequence":"additional","affiliation":[{"name":"Thrombosis Research Institute, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo G.","family":"Mantovani","sequence":"additional","affiliation":[{"name":"Center for Public Health Research, University of Milan Bicocca, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Misselwitz","sequence":"additional","affiliation":[{"name":"Bayer AG Pharmaceuticals, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Pieper","sequence":"additional","affiliation":[{"name":"Thrombosis Research Institute, London, England"},{"name":"Duke Clinical Research Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G. G.","family":"Turpie","sequence":"additional","affiliation":[{"name":"McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek W. A.","family":"Verheugt","sequence":"additional","affiliation":[{"name":"Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Kakkar","sequence":"additional","affiliation":[{"name":"University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the GARFIELD-AF Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"23","key":"hoi180075r1","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"23","key":"hoi180075r2","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/eurheartj\/ehl359","article-title":"Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure.","volume":"27","author":"Pedersen","year":"2006","journal-title":"Eur Heart J"},{"issue":"7","key":"hoi180075r3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/eurjhf\/hfq052","article-title":"Atrial fibrillation in heart failure is associated with an increased risk of death only in patients with ischaemic heart disease.","volume":"12","author":"Rauns\u00f8","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"hoi180075r4","doi-asserted-by":"publisher","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"hoi180075r5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ahj.2011.09.011","article-title":"International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).","volume":"163","author":"Kakkar","year":"2012","journal-title":"Am Heart J"},{"issue":"2","key":"hoi180075r6","first-page":"114","article-title":"Evolving quality standards for large-scale registries: the GARFIELD-AF experience.","volume":"3","author":"Fox","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"hoi180075r7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijcard.2016.08.316","article-title":"Mortality in systolic heart failure revisited: ischemic versus non-ischemic cardiomyopathy.","volume":"224","author":"Gajanana","year":"2016","journal-title":"Int J Cardiol"},{"issue":"4","key":"hoi180075r8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0735-1097(97)00235-0","article-title":"Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy.","volume":"30","author":"Bart","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"hoi180075r9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.","volume":"342","author":"Felker","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"hoi180075r10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0735-1097(98)00400-8","article-title":"Etiology and response to drug treatment in heart failure.","volume":"32","author":"Follath","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi180075r11","first-page":"181","article-title":"Ischemic versus non-ischemic cardiomyopathy: are there differences in prognosis? experience of an advanced heart failure center.","volume":"30","author":"Louren\u00e7o","year":"2011","journal-title":"Rev Port Cardiol"},{"issue":"1","key":"hoi180075r12","first-page":"56","article-title":"Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors.","volume":"11","author":"Moscinski","year":"2014","journal-title":"Kardiochir Torakochirurgia Pol"},{"issue":"2","key":"hoi180075r13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2007.07.014","article-title":"Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.","volume":"129","author":"Ng","year":"2008","journal-title":"Int J Cardiol"},{"issue":"11, suppl 1","key":"hoi180075r14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1161\/CIRCULATIONAHA.111.084434","article-title":"Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability.","volume":"126","author":"Kwon","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"hoi180075r15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10741-017-9657-9","article-title":"Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure.","volume":"23","author":"Hohendanner","year":"2018","journal-title":"Heart Fail Rev"},{"key":"hoi180075r16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pharmthera.2016.10.019","article-title":"Atrial fibrillation in heart failure with preserved ejection fraction: insights into mechanisms and therapeutics.","volume":"176","author":"Patel","year":"2017","journal-title":"Pharmacol Ther"},{"issue":"6","key":"hoi180075r17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/eurheartj\/ehx730","article-title":"Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.","volume":"39","author":"Verheugt","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi180075r18","doi-asserted-by":"publisher","first-page":"e0191592","DOI":"10.1371\/journal.pone.0191592","article-title":"Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: rationale for comprehensive management of atrial fibrillation.","volume":"13","author":"Bassand","year":"2018","journal-title":"PLoS One"},{"issue":"38","key":"hoi180075r19","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","article-title":"Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.","volume":"37","author":"Bassand","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"hoi180075r20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ahj.2008.06.029","article-title":"Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.","volume":"156","author":"Goto","year":"2008","journal-title":"Am Heart J"},{"key":"hoi180075r21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2147\/CIA","article-title":"Medication regimen complexity in ambulatory older adults with heart failure.","volume":"12","author":"Cobretti","year":"2017","journal-title":"Clin Interv Aging"},{"issue":"3","key":"hoi180075r22","doi-asserted-by":"publisher","first-page":"e017765","DOI":"10.1136\/bmjopen-2017-017765","article-title":"Effectiveness of implementation interventions in improving physician adherence to guideline recommendations in heart failure: a systematic review.","volume":"8","author":"Shanbhag","year":"2018","journal-title":"BMJ Open"},{"issue":"11","key":"hoi180075r23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/ejhf.2017.19.issue-11","article-title":"Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis.","volume":"19","author":"Van Spall","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"hoi180075r24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/xJAHA.111.000018","article-title":"Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case-control analysis of IMPROVE HF.","volume":"1","author":"Fonarow","year":"2012","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"hoi180075r25","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.114.013451","article-title":"Doing the right things and doing them the right way: association between hospital guideline adherence, dosing safety, and outcomes among patients with acute coronary syndrome.","volume":"131","author":"Mehta","year":"2015","journal-title":"Circulation"},{"issue":"17","key":"hoi180075r26","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/CIRCULATIONAHA.114.013760","article-title":"Risk of stroke in chronic heart failure patients without atrial fibrillation: analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Insufficienza Cardiaca-Heart Failure (GISSI-HF) trials.","volume":"131","author":"Abdul-Rahim","year":"2015","journal-title":"Circulation"},{"issue":"10","key":"hoi180075r27","first-page":"742","article-title":"Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.","volume":"38","author":"Abdul-Rahim","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi180075r28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5853\/jos.2017.02810","article-title":"Heart failure as a risk factor for stroke.","volume":"20","author":"Kim","year":"2018","journal-title":"J Stroke"},{"issue":"24","key":"hoi180075r29","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1016\/j.jacc.2014.03.039","article-title":"Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study.","volume":"63","author":"Lamberts","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"hoi180075r30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CRD.0000000000000088","article-title":"Non-vitamin K antagonist oral anticoagulants and antiplatelet therapy for stroke prevention in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.","volume":"24","author":"Kumar","year":"2016","journal-title":"Cardiol Rev"},{"issue":"1","key":"hoi180075r31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.amjcard.2017.03.256","article-title":"The population-based long-term impact of anticoagulant and antiplatelet therapies in low-risk patients with atrial fibrillation.","volume":"120","author":"Golive","year":"2017","journal-title":"Am J Cardiol"},{"issue":"14","key":"hoi180075r32","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jacc.2015.01.044","article-title":"Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.","volume":"65","author":"Lip","year":"2015","journal-title":"J Am Coll Cardiol"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamacardiology\/article-pdf\/4\/6\/526\/17664499\/jamacardiology_corbalan_2019_oi_180075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T15:01:12Z","timestamp":1560956472000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2018.4729"}},"subtitle":["A Report From the GARFIELD-AF Registry"],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2018.4729","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}